---
document_datetime: 2023-09-21 21:10:00
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_en.pdf
document_name: senstend-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.738375
conversion_datetime: 2025-12-24 16:32:09.371366
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength             | Pharmaceutical Form       | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size              |
|------------------|-------------------|----------------------|---------------------------|---------------------------|-----------------------|---------------------------|------------------------|
| EU/1/19/1387/001 | Senstend          | 150 mg/ml / 50 mg/ml | Cutaneous spray, solution | Cutaneous use             | spray container (alu) | 6.5 ml                    | 1 container (20 doses) |
| EU/1/19/1387/002 | Senstend          | 150 mg/ml / 50 mg/ml | Cutaneous spray, solution | Cutaneous use             | spray container (alu) | 5 ml                      | 1 container (12 doses) |

<!-- image -->